Abstract
Background
Cathepsin S is a member of the family of cysteine lysosomal proteases. The distribution of cathepsin S is restricted to cells from the mononuclear lineage both in the brain and in the periphery. Also, its protease activity is uniquely stable at neutral pH.
Materials and Methods
We compared the expression of cathepsin S, B, and L mRNAs in various undifferentiated and differentiated cells of mononuclear origin, and examined the modulation of these mRNAs by inflammatory mediators (lipopolysaccharide and various cytokines). In addition, the effect of these agents on cathepsin S protein levels and protease activity was also determined. Lastly, the ability of cathepsin S to process basement membrane components such as heparan sulfate proteoglycans in vitro and in vivo was assessed.
Results
Cathepsin S, B, and L mRNAs are expressed in mature macrophages and microglial cells and not in undifferentiated monocytes. Activators of macrophages negatively regulate all three transcripts. Consistent with this, treatment with these agents leads to a decrease in intracellular cathepsin S protein levels and activity. However, the same treatments result in stimulation of secreted cathepsin S activity. Cathepsin S is capable of degrading heparan sulfate proteoglycans in vitro. Also, when expressed in endothelial cells, cathepsin S autocrinely attenuates the basic fibroblast growth factor (bFGF)-mediated binding of FGF receptor containing cells to endothelial cells, by acting on basement membrane proteoglycans.
Conclusions
Taken together, these data imply that cathepsin S is a regulatable cysteine protease that plays a role in the degradation of extracellular proteins, whose secretion from macrophages and microglia is increased by signals that lead to activation of these cells, and may be important in regulating extracellular matrix interactions.
Similar content being viewed by others
References
Perry VH, Gordon S. (1991) Macrophages and the nervous system. Int. Rev. Cytol. 125: 203–244.
Adams DO, Hamilton TA. (1984) The cell biology of macrophage activation Annu. Rev. Immunol. 2: 283–318.
Page RC, Davies P, Allison AC. (1978) The macrophage as a secretory cell Int. Rev. Cytol. 52: 119–157.
Nathan CF. (1987) Secretory products of macrophages. J. Clin. Invest. 79: 319–326.
Gelb BD, Shi GP, Heller M, et al. (1997) Structure and chromosomal assignment of the human cathepsin K gene. Genomics 41: 258–262.
Kirschke H. (1994) Cathepsin S and related lysosomal endopeptidases. Methods Enzymol. 244: 500–511.
Bromme D, Okamoto K, Wang BB, Biroc S. (1996) Human cathepsin 02, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin 02 in Spodoptera frugiperda and characterization of the enzyme. J. Biol. Chem. 271: 2126–2132.
Bromme D, Steinert A, Friebe S, Fittkau S, Wiederanders B, Kirschke H. (1989) The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B. Biochem. J. 264: 475–481.
Kirschke H, Wiederanders B, Bromme D, Rinne A. (1989) Cathepsin S from bovine spleen. Purification distribution intracellular localization and action on proteins. Biochem. J. 264: 467–473.
Maciewicz RA, Etherington DJ. (1988) A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. Biochem. J. 256: 433–440.
Petanceska S, Canoll P, Devi LA. (1996) Expression of rat cathepsin S in phagocytic cells. J. Biol. Chem. 271: 4403–4409.
Shi G-P, Munger JS, Meara JP, Rich DH, Chapman HA. (1992) Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267: 7258–7262.
Shi G-P, Webb AC, Foster KE, et al. (1994) Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J. Biol. Chem. 269: 11530–11536.
Basilico C, Moscatelli D. (1992) The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59: 115–165.
Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. (1994) Perlecan basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79: 1005–1013.
Schlessinger J, Lax I, Lemmon M. (1995) Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 83: 357–360.
Liuzzo JP, Moscatelli D. (1996) Human leukemia cell lines bind basic fibroblast growth factor (FGF) on FGF receptors and heparan sulfates: down-modulation of FGF receptors by phorbol ester. Blood 87: 245–255.
Richard C, Liuzzo JP, Moscatelli D. (1995) Fibroblast growth factor-2 can mediate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells. J. Biol. Chem. 270: 24188–24196.
Roghani M, Mansukhani A, Dell’Era P, et al. (1994) Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269: 3976–3984.
Petanceska S, Burke S, Watson SJ, Devi LA. (1994) Differential distribution of messenger RNAs for cathepsins B, L and S in adult rat brain: an in situ hybridization study. Neuroscience 59: 729–730.
Petanceska S, Devi L. (1992) Sequence analysis, tissue distribution, and expression of rat cathepsin S. J. Biol. Chem. 267: 26038–26043.
Reddy VY, Zhang Q-Y, Weiss SJ. (1995) Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. U.S.A. 92: 3849–3853.
Reilly JJ, Mason RW, Chen P, Joseph LJ, Sukhatme VP, Yee R. (1989) Synthesis and processing of cathepsin L, an elastase, by human alveolar macrophages. Biochem. J. 257: 493–498.
Reilly JJ, Chen P, Sailor LZ, Mason RW, Chapman HA. (1990) Uptake of extracellular enzyme by a novel pathway is a major determinant of cathepsin L levels in human macrophages. J. Clin. Invest. 86: 176–183.
Li Q, Ding L, Bever CT. (1998) Interferon-c induces cathepsin B expression in a human macrophage-like cell line by increasing both transcription and mRNA stability. Int. J. Mol. Med. 2: 181–186.
Schubert D, Schroeder R, LaCorbiere M, Saitoh T, Cole G. (1988) Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein. Science 241: 223–226.
Shioi J, Anderson JP, Ripellino JA, Robakis NK. (1992) Chondroitin sulfate proteoglycan form of the Alzheimer’s beta-amyloid precursor. J. Biol. Chem. 267: 13819–13822.
Brunner G, Gabrilove J, Rifkin DB, Wilson EL. (1991) Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan. J. Cell. Biol. 114: 1275–1283.
Saksela O, Moscatelli D, Sommer A, Rifkin DB. (1988) Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107: 743–751.
Recklies AD, Mort JS, Poole AR. (1982) Secretion of a thiol proteinase from mouse mammary carcinomas and its characterization. Cancer Res. 42: 1026–1032.
Morland B, Pedersen A. (1979) Cathepsin B activity in stimulated mouse peritoneal macrophages. Lab. Invest. 41: 379–384.
Portnoy DA, Erickson AH, Kochan J, Ravetch JV, Unkeless JC. (1986) Cloning and characterization of a mouse cysteine proteinase. J. Biol. Chem. 261: 14697–14703.
Giulian D, Corpuz M. (1993) Microglial secretion products and their impact on the nervous system. Adv. Neurol. 59: 315–320.
Mason RW, Wilcox D. (1993) Chemistry of lysosomal cysteine proteinases. Adv. Cell Mol. Biol. Memb. 1: 81–116.
Morrison RIG, Barrett AJ, Dingle JT, Prior D. (1973) Cathepsins BI and D. Action on human cartilage proteoglycans. Biochim. Biophys. Acta 302: 411–419.
Isemura M, Yosizawa Z, Takahashi K, Kosaka H, Kojima N, Ono T. (1981) Characterization of porcine plasma fibronectin and its fragmentation by porcine liver cathepsin B. J. Biochem. 90: 1–9.
Burleigh MC, Barrett AJ, Lazarus GS. (1974) Cathepsin B1. A lysosomal enzyme that degrades native collagen. Biochem. J. 137: 387–398.
Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF. (1992) Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem. J. 282: 273–278.
Gal S, Gottesman MM. (1986) The major excreted protein of transformed fibroblasts is an activable acid-protease. J. Biol. Chem. 261: 1760–1765.
Kirschke H, Kembhavi AA, Bohley P, Barrett AJ. (1982) Action of rat liver cathepsin L on collagen and other substrates. Biochem. J. 201: 367–372.
Mason RW, Johnson DA, Barrett AJ, Chapman HA. (1986) Elastinolytic activity of human cathepsin L. Biochem. J. 233: 925–927.
Liotta LA. (1986) Tumor invasion and metastases—role of the extracellular matrix. Cancer Res. 46: 1–7.
Sloane BF. (1990) Cathepsin B and cystatins: evidence for a role in cancer progression. Semin. Cancer Biol. 1: 137–152.
Mason RW, Wilcox D, Wikstrom P, Shaw EN. (1989) The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabeled inhibitor. Biochem. J. 257: 125–129.
Warfel AH, Zucker-Franklin D, Frangione B, Ghiso J. (1987) Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its down-regulation after stimulation. J. Exp. Med. 166: 1912–1917.
Perry VH, Andersson P-B, Gordon S. (1993) Macrophages and inflammation in the central nervous system. Trends Neurosci. 16: 268–273.
Rappolee DA, Werb Z. (1992) Macrophage-derived growth factors. Curr. Top. Microbiol. Immunol. 181: 87–140.
Broudy VC, Kaushansky K, Harlan JM, Adamson JW. (1987) Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. J. Immunol. 139: 464–468.
Broudy VC, Kaushansky K, Segal GM, Harlan JM, Adamson JW. (1986) Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 83: 7467–7471.
Munker R, Gasson J, Ogawa M, Koeffler HP. (1986) Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 323: 79–82.
Heremans A, De Cock B, Cassiman JJ, Van den Berghe H, David G. (1990) The core protein of the matrix-associated heparan sulfate proteoglycan binds to fibronectin. J. Biol. Chem. 265: 8716–8724.
Clement B, Yamada Y. (1990) A Mr 80K hepatocyte surface protein(s) interacts with basement membrane components. Exp. Cell Res. 187: 320–323.
Singer II, Scott S, Kawka DW, Hassell JR. (1987) Extracellular matrix fibers containing fibronectin and basement membrane heparan sulfate proteoglycan coalign with focal contacts and microfilament bundles in stationary fibroblasts. Exp. Cell Res. 173: 558–571.
Rapraeger AC, Ott VL. (1998) Molecular interactions of the syndecan core proteins. Curr. Opin. Cell Biol. 10: 620–628.
Acknowledgments
This work was supported in part by National Institute of Health grants NS 26880 and NS K04 1788 (to L. A. D.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liuzzo, J.P., Petanceska, S.S., Moscatelli, D. et al. Inflammatory Mediators Regulate Cathepsin S in Macrophages and Microglia: A Role in Attenuating Heparan Sulfate Interactions. Mol Med 5, 320–333 (1999). https://doi.org/10.1007/BF03402068
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03402068